Our diverse R&D pipeline is developed by harnessing our technology to create safe and effective vaccines targeting global health burdens. Among them, recombinant herpes zoster vaccine (CHO cell) and recombinant trivalent rotavirus subunit vaccine have entered the clinical stage.
Clinical projects
Preclinical items
Projects in the plan
Clinical experiment: clinical phase II
Clinical experiment: clinical phase II
Candidate products
Proof of concept
Preclinical
IND
Phase I clinical trial
Phase II clinical trial
Phase III clinical trial
Zoster vaccine
Phase I clinical trial
Injection of rotavirus vaccine
Phase I clinical trial
Oral rotavirus vaccine
Preclinical
COVID-19 vaccine
Preclinical
Therapeutic HPV vaccine
Proof of concept
Rabies vaccine (two doses)
Proof of concept
Varicella vaccine
Preclinical